The Complex Process of Developing New Medications

Target Identification & Lead Discovery

The process begins with identifying a specific biological target—often a protein or enzyme—involved in a disease. This ‘target’ represents the point where a drug can exert its effect. Techniques like genomics, proteomics, and bioinformatics are used to pinpoint these targets.

Lead Optimization & Preclinical Studies

Once a potential target is identified, researchers search for ‘lead compounds’ – molecules that show promise in interacting with the target. These leads are then optimized through chemical modifications to improve their efficacy and safety profiles. Extensive preclinical studies (in vitro and in vivo) assess these properties.

ΔG = -RTlnK  (Change in Gibbs Free Energy relates to binding affinity)

Clinical Trials: Assessing Safety & Efficacy

If preclinical results are promising, the lead compound enters clinical trials. These trials progress through three phases: Phase I (safety), Phase II (efficacy and dosage), and Phase III (large-scale efficacy confirmation). Each phase involves rigorous data collection and statistical analysis.

Post-Market Surveillance & Regulatory Approval

Following successful clinical trials, a drug application is submitted to regulatory agencies like the FDA. Post-market surveillance monitors for rare side effects or unexpected issues. Continuous research and development ensure ongoing improvements and new formulations.

Frequently asked questions

Try it live

Everything above runs in your browser — open Reaction-Diffusion and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.